Abstract
This article describes the use of 18F-fluorodeoxyglucose PET in patients who have head and neck cancer for assessment of therapy response, detection of locoregional recurrence and distant metastasis, and surveillance.
Original language | English (US) |
---|---|
Pages (from-to) | 481-487 |
Number of pages | 7 |
Journal | PET Clinics |
Volume | 2 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2007 |
Keywords
- Head and neck
- PET/CT
- Squamous cell carcinoma
- Surveillance
- Therapy response
ASJC Scopus subject areas
- Radiation
- Radiology Nuclear Medicine and imaging